Romania · Delayed Price · Currency is RON Biofarm Statistics
Total Valuation
Biofarm has a market cap or net worth of RON 1.23 billion. The enterprise value is 1.06 billion.
| Market Cap | 1.23B |
| Enterprise Value | 1.06B |
Important Dates
The next confirmed earnings date is Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | May 13, 2026 |
Share Statistics
Biofarm has 985.37 million shares outstanding. The number of shares has increased by 0.75% in one year.
| Current Share Class | 985.37M |
| Shares Outstanding | 985.37M |
| Shares Change (YoY) | +0.75% |
| Shares Change (QoQ) | +43.55% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 88.43% |
| Float | 476.14M |
Valuation Ratios
The trailing PE ratio is 13.52.
| PE Ratio | 13.52 |
| Forward PE | n/a |
| PS Ratio | 3.84 |
| PB Ratio | 2.24 |
| P/TBV Ratio | 2.25 |
| P/FCF Ratio | 18.63 |
| P/OCF Ratio | 15.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.23, with an EV/FCF ratio of 16.06.
| EV / Earnings | 10.51 |
| EV / Sales | 3.31 |
| EV / EBITDA | 9.23 |
| EV / EBIT | 11.01 |
| EV / FCF | 16.06 |
Financial Position
The company has a current ratio of 4.95, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.95 |
| Quick Ratio | 3.92 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 19.60% and return on invested capital (ROIC) is 23.07%.
| Return on Equity (ROE) | 19.60% |
| Return on Assets (ROA) | 10.08% |
| Return on Invested Capital (ROIC) | 23.07% |
| Return on Capital Employed (ROCE) | 17.47% |
| Weighted Average Cost of Capital (WACC) | 7.08% |
| Revenue Per Employee | 865,406 |
| Profits Per Employee | 272,719 |
| Employee Count | 367 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 0.84 |
Taxes
In the past 12 months, Biofarm has paid 14.35 million in taxes.
| Income Tax | 14.35M |
| Effective Tax Rate | 12.48% |
Stock Price Statistics
The stock price has increased by +83.63% in the last 52 weeks. The beta is 0.52, so Biofarm's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +83.63% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 0.94 |
| Relative Strength Index (RSI) | 49.14 |
| Average Volume (20 Days) | 53,785 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biofarm had revenue of RON 319.33 million and earned 100.63 million in profits. Earnings per share was 0.09.
| Revenue | 319.33M |
| Gross Profit | 270.41M |
| Operating Income | 96.11M |
| Pretax Income | 114.99M |
| Net Income | 100.63M |
| EBITDA | 114.64M |
| EBIT | 96.11M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 170.25 million in cash and 1.13 million in debt, with a net cash position of 169.11 million or 0.17 per share.
| Cash & Cash Equivalents | 170.25M |
| Total Debt | 1.13M |
| Net Cash | 169.11M |
| Net Cash Per Share | 0.17 |
| Equity (Book Value) | 548.35M |
| Book Value Per Share | 0.56 |
| Working Capital | 342.85M |
Cash Flow
In the last 12 months, operating cash flow was 80.52 million and capital expenditures -14.67 million, giving a free cash flow of 65.86 million.
| Operating Cash Flow | 80.52M |
| Capital Expenditures | -14.67M |
| Depreciation & Amortization | 18.53M |
| Net Borrowing | n/a |
| Free Cash Flow | 65.86M |
| FCF Per Share | 0.07 |
Margins
Gross margin is 84.68%, with operating and profit margins of 30.10% and 31.51%.
| Gross Margin | 84.68% |
| Operating Margin | 30.10% |
| Pretax Margin | 36.01% |
| Profit Margin | 31.51% |
| EBITDA Margin | 35.90% |
| EBIT Margin | 30.10% |
| FCF Margin | 20.62% |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 2.49%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 2.49% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 29.05% |
| Buyback Yield | -0.75% |
| Shareholder Yield | 1.74% |
| Earnings Yield | 8.20% |
| FCF Yield | 5.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 30, 2008. It was a forward split with a ratio of 1.12001.
| Last Split Date | Apr 30, 2008 |
| Split Type | Forward |
| Split Ratio | 1.12001 |
Scores
Biofarm has an Altman Z-Score of 7.73 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.73 |
| Piotroski F-Score | 5 |